About The Morgan Adams Foundation
Working with leading researchers and physicians, The Morgan Adams Foundation funds new and innovative ideas that will improve cancer treatment effectiveness, overall outcomes, survival rates, and quality of life while minimizing the devastating side effects current treatments have on children and young adults.
The Work of The Foundation
The Morgan Adams Foundation funds translational studies, experimental therapeutics studies, and Phase I and II clinical trials, as well as laboratory and clinical research, and seed and bridge grants for viable investigations not yet ripe for total funding by larger organizations.
In 2003, MAF began funding “Gene Chips,” which allowed researchers to analyze over 50,000 genes simultaneously and provide more insight into cancerous tumors. As technology has advanced, MAF continues to invest in new, emerging types of genomic analysis giving doctors and researchers even more insight into the drivers of pediatric cancers.